Data gathered: January 24
AI Stock Analysis - Amedisys (AMED)
Analysis generated September 26, 2024. Powered by Chat GPT.
Amedisys, Inc. is a home health care company based in Baton Rouge, Louisiana. The firm primarily operates in three segments: Home Health Care, Hospice Care, and Personal Care. Amedisys delivers a broad range of health care services to enable its patients to recover comfortably at home, thus reducing hospital readmission rates and lowering overall costs. With a robust network of compassionate healthcare professionals, Amedisys has established itself as a pivotal player in the home health care industry, committed to improving the quality of life for its patients.
Stock Alerts - Amedisys (AMED)
Amedisys | January 11 Web Traffic is up by 69.8% over the last month. |
|
Amedisys | January 3 AI Score is up by 20.1% in the last couple of days. |
|
Amedisys | December 3 Price is down by -5.2% in the last 24h. |
|
Amedisys | November 11 Price is down by -5.9% in the last 24h. |
Alternative Data for Amedisys
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 1,773 | Sign up | Sign up | Sign up | |
Sentiment | 50 | Sign up | Sign up | Sign up | |
Webpage traffic | 95,000 | Sign up | Sign up | Sign up | |
Employee Rating | 66 | Sign up | Sign up | Sign up | |
Google Trends | 48 | Sign up | Sign up | Sign up | |
Patents | N/A | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 85 | Sign up | Sign up | Sign up | |
Facebook Followers | 16,284 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 816 | Sign up | Sign up | Sign up | |
Twitter Followers | 1,220 | Sign up | Sign up | Sign up | |
Twitter Mentions | 6 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 274 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
Business Outlook | 54 | Sign up | Sign up | Sign up | |
Linkedin Employees | 8,979 | Sign up | Sign up | Sign up |
About Amedisys
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care.
Price | $92.58 |
Target Price | Sign up |
Volume | 63,410 |
Market Cap | $3.02B |
Year Range | $83.78 - $98.45 |
Dividend Yield | 0% |
PE Ratio | 36.54 |
Analyst Rating | 20% buy |
Industry | Medical Care Facilities |
In the news
North America Home Healthcare Market Analysis Report 2024 Featuring United Health, CVS, Amedisys, and Maxim Healthcare - Key Financial Metrics and Analysis of Competitive Pressures 2023-2028January 20 - GlobeNewswire |
|
JPMorgan Chase & Co. Sells 4,307 Shares of Amedisys, Inc. (NASDAQ:AMED)January 15 - ETF Daily News |
|
HBW Advisory Services LLC Acquires Shares of 416 Amedisys, Inc. (NASDAQ:AMED)January 12 - ETF Daily News |
|
Amedisys, Inc. (NASDAQ: AMED) Terminates Purchase Agreement with VCG LunaJanuary 10 - ETF Daily News |
|
UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaringJanuary 8 - Yahoo |
|
Amedisys, Inc. (NASDAQ:AMED) Stock Position Raised by Versant Capital Management IncJanuary 7 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q3 '24 | 588M | 692M | -104M | 17M | 35M | 0.000 |
Q2 '24 | 591M | 668M | -77M | 32M | 61M | 1.320 |
Q1 '24 | 571M | 668M | -96M | 14M | 39M | 1.030 |
Q4 '23 | 571M | 673M | -681M | 19M | 36M | 0.940 |
Q3 '23 | 556M | 643M | -651M | 26M | 51M | 0.980 |
Insider Transactions View All
North Michael Paul filed to sell 4,164 shares at $86.4. March 8 '23 |
Bohnert Denise M. filed to sell 11,850 shares at $115. June 27 '22 |
Kemmerly David L filed to sell 18,816 shares at $175.2. April 4 '22 |
Kemmerly David L filed to sell 16,336 shares at $177.9. April 4 '22 |
Kemmerly David L filed to sell 16,779 shares at $177.2. April 4 '22 |
Similar companies
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Rohit Khanna Democrat |
Apr 7, 23 | Sell | $1K - $15K |
Rohit Khanna Democrat |
Apr 7, 23 | Sell | $1K - $15K |
Rohit Khanna Democrat |
Mar 8, 23 | Buy | $1K - $15K |
Read more about Amedisys (AMED) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Amedisys?
The Market Cap of Amedisys is $3.02B.
What is Amedisys' PE Ratio?
As of today, Amedisys' PE (Price to Earnings) ratio is 36.54.
What is the current stock price of Amedisys?
Currently, the price of one share of Amedisys stock is $92.58.
How can I analyze the AMED stock price chart for investment decisions?
The AMED stock price chart above provides a comprehensive visual representation of Amedisys' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amedisys shares. Our platform offers an up-to-date AMED stock price chart, along with technical data analysis and alternative data insights.
Does AMED offer dividends to its shareholders?
As of our latest update, Amedisys (AMED) does not offer dividends to its shareholders. Investors interested in Amedisys should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Amedisys?
Some of the similar stocks of Amedisys are Encompass Health, Brookdale Senior Living, DaVita, Tenet Healthcare, and Encompass Health.
.